To UM home page

Researcher

Pouwels, X.G.L.V.

Researcher (MUMC)

View graph of relations
1 - 8 out of 8Page size: 50
  1. 2019
  2. Published
    Grimm, S. E., Fayter, D., Ramaekers, B. L. T., Petersohn, S., Riemsma, R., Armstrong, N., ... Joore, M. A. (2019). Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(10), 1195-1207. https://doi.org/10.1007/s40273-019-00792-7
  3. Published
    Ramaekers, B. L. T., Riemsma, R., Grimm, S., Fayter, D., Deshpande, S., Armstrong, N., ... Joore, M. A. (2019). Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(7), 887-894. https://doi.org/10.1007/s40273-018-0738-y
  4. Published
    Pouwels, X. G. L. V., Grutters, J. P. C., Bindels, J., Ramaekers, B. L. T., & Joore, M. A. (2019). Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory? Value in Health, 22(7), 799-807. https://doi.org/10.1016/j.jval.2018.11.010
  5. Published
    Grimm, S. E., Armstrong, N., Ramaekers, B. L. T., Pouwels, X., Lang, S., Petersohn, S., ... Joore, M. A. (2019). Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(5), 655-667. https://doi.org/10.1007/s40273-018-0723-5
  6. 2018
  7. Published
    Ramaekers, B. L. T., Wolff, R. F., Pouwels, X., Oosterhoff, M., Van Giessen, A., Worthy, G., ... Joore, M. A. (2018). Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36(8), 917-927. https://doi.org/10.1007/s40273-018-0629-2
  8. Published
    Pouwels, X. G. L. V., Wolff, R., Ramaekers, B. L. T., Van Giessen, A., Lang, S., Ryder, S., ... Joore, M. A. (2018). Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36(5), 533-543. https://doi.org/10.1007/s40273-017-0607-0
  9. Published
    Ramaekers, B. L. T., Wolff, R., van Giessen, A., Pouwels, X., Fayter, D., Lang, S., ... Joore, M. A. (2018). Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36(3), 285-288. https://doi.org/10.1007/s40273-017-0591-4
  10. 2017
  11. Published
    Pouwels, X. G. L. V., Ramaekers, B. L. T., & Joore, M. A. (2017). Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer. Breast Cancer Research and Treatment, 165(3), 485-498. https://doi.org/10.1007/s10549-017-4374-6

UM postal address
P.O. Box 616
6200 MD Maastricht
The Netherlands

UM visiting address
Minderbroedersberg 4-6
6211 LK Maastricht
The Netherlands
Phone: +31 43 388 2222

Quick Links